Skip to content

The effect of combined decongestive therapy and pneumatic compression pump on lymphedema indicators and body image in patients with lymphedema secondary to breast cancer treatment

The effect of combined decongestive therapy and pneumatic compression pump on lymphedema indicators and body image in patients with lymphedema secondary to breast cancer treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT138902212621N8
Enrollment
48
Registered
2011-04-30
Start date
2009-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postmastectomy lymphedema. Postmastectomy lymphoedema syndrome

Interventions

Intervention 1: Patients in in the control group received no treatment for lymphedema. Intervention 2: CDT in the intervention group was done in two phases. In the first phase CDT was performed with a
Treatment - Devices
Patients in in the control group received no treatment for lymphedema.
CDT in the intervention group was done in two phases. In the first phase CDT was performed with a compression pump for 4 weeks, 3 days per week. In the second phase, CDT was performed daily without a

Sponsors

Shiraz university of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1.histoty of breast cancer, 2.history of surgery and chemotherapy and as needed hormone therapy and radiotherapy, 3. affected by lymphedema (with degree of mild to severe) based on specialist diagnosis, 4. at least 1 year ago was undergone axillary node dissection, 5. do not have knowledge about combined decongestive therapy, 6. phone accessibility, 7. 35-70 years old. Exclusion criteria: 1. psychotic disorder, 2. existence sever pain at axillary area, 3. history of hysterectomy duo to uterus cancer, 4. severe cardiac disease, 5. heart failure, 6. renal failure, 7. severe hypertension, 8. existing other malignancies, 9. recurrent infection in arm, 10. musclo skeletal disease

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Differences in volume of both upper limbs. Timepoint: before the intervention, 4 and 8 weeks after that. Method of measurement: volumeter.;Difference in circumference between the two upper limbs. Timepoint: before the intervention, 4 and 8 weeks after that. Method of measurement: meter.;Shoulder joint range of motion. Timepoint: before the intervention, 4 and 8 weeks after that. Method of measurement: goniometer.;Body image and relationships. Timepoint: before the intervention, 4 and 8 weeks after that. Method of measurement: body image and relationships scale (questionare).

Secondary

MeasureTime frame
Adduction motion of shoulder joint. Timepoint: before the intervention, 4 and 8 weeks after that. Method of measurement: goniometer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBadri Jaafari

Shiraz university of medical sciences

jafary_227@yahoo.com+98 71 1835 2694

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026